{"retracted":false,"update":{"timestamp":1472688000000,"doi":"10.1016/j.dld.2016.06.015","type":"erratum"},"doi":"10.1016/j.dld.2015.12.016","journal":"Digestive and Liver Disease","publisher":"Elsevier BV","title":"Corrigendum to “Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease” [Dig. Liver Dis. 48 (2016) 360–370]"}
